Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Manufacture of Chlorine Test Reagent (DPD Powder Pillows)

Active

Federal

Response Deadline08/03/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the manufacture of DPD total chlorine test reagent in powder pillow form, specifically designed to meet the Technical Data Package specifications established by the Defense Logistics Agency for use in medical water testing applications. The product must adhere to strict quality control standards to ensure consistent performance, accurate measurement of chlorine levels, and compatibility with certified testing protocols used in military medical facilities. The reagent is intended for deployment in field and clinical settings where reliable water safety verification is critical to health and operational readiness. Production must comply with the NAICS code 325412 for chemical manufacturing, and the place of performance is designated as FPO, 09591-0100, indicating delivery to military logistics channels. The opportunity is structured as a subcontract under the Department of Defense’s Medical Supply Chain, with responses due by August 3, 2026. Manufacturers must demonstrate capability in producing pharmaceutical-grade reagents with validated batch consistency, packaging integrity, and shelf-life stability under operational storage conditions. No set-aside type is specified, meaning the contract is open to all qualified vendors regardless of business size or ownership structure.

General Info

Manufacture DPD total chlorine test reagent in powder pillow form for military medical water testing under strict quality standards.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSFView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AE, 09591-0100, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 26

subcontract

Response DeadlineAug 3

Submission deadline

Response Deadline

08/03/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and quality control of DPD total chlorine test reagent in powder pillow form, meeting DLA technical specifications for medical water testing.

Similar Contracts

Same NAICS industry code

Medical Electrode Gel Manufacturing and SupplyThe contract entails the manufacture and delivery of a specialized electrode gel designed for EKG applications, requiring the product to be clear, salt-free, non-staining, and corrosion-resistant to ensure optimal performance and patient safety. The gel must be packaged in 8.5 oz tubes, with twelve tubes per box, and must maintain its integrity and effectiveness over a 48-month shelf life, ensuring long-term usability without degradation. Delivery terms specify FOB Destination to Scott AFB, IL, indicating the vendor assumes responsibility for all shipping costs and risks until the product reaches the designated military location. The solicitation is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is issued by the Department of Defense through its Medical Supply Chain division. Responses are due by August 3, 2026, with the opportunity posted on July 26, 2026, suggesting a competitive bidding window of approximately one week to secure the supply agreement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 250 mL units, packaged 24 bags per purchase group, is being procured under solicitation SPE2DP-26-T-4271 with a delivery requirement of five days FOB destination. The item is regulated by the FDA and must comply with strict packaging and marking standards as defined by Medical Marking Standard No. 1, superseding all references to MIL-STD-129. Each unit must be sealed in commercial-grade containers that protect against damage and breakage, and all exterior shipping containers must ensure safe, cost-effective delivery by common carriers. The product has a non-extendable shelf life of 24 months and must be stored at room temperature with brief exposure to up to 40°C permitted without adverse effect. The item is identified by NSN 6505-01-331-8945 and is subject to zero variance in quantity, with inspection and acceptance occurring at the destination. Multiple manufacturers including B. Braun Medical Inc., ICU Medical Inc., Trillamed LLC, and Cardinal Health 200, LLC are qualified suppliers, each identified by specific NDC numbers and part numbers. All packaging and labeling must conform to the latest Medical Marking Standard No. 1, available through DLA Troop Support, and the solicitation includes requirements for covered defense information. The contracting officer must submit a referral in EBS for product confirmation prior to award, including bidder and manufacturer details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ACEPROMAZINE MALEATE IACEPROMAZINE MALEATE INJECTION, VETERINARY, 10MG/ML in 50ML vials, is being procured under solicitation SPE2DP-26-T-4274 for use in cats, dogs, and horses, with explicit prohibition against use in horses intended for human consumption. The unit of issue is a vial (VI), and the contract calls for delivery of two vials, with a firm fixed price of $25.03 per vial, resulting in a total estimated contract value of approximately $1,078. Delivery is required within 62 days after award, FOB destination, to a designated military medical logistics center in Kaiserslautern, Germany. The product must be stored at controlled room temperature, between 20–25°C (68–77°F), and carries a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Packaging must strictly adhere to MIL-STD-2073-1E, and all marking must comply with the latest Medical Marking Standard No. 1, superseding MIL-STD-129. As a hazardous material, the product requires GHS-compliant labeling under OSHA’s Hazard Communication Standard (29 CFR 1910.1200), with Safety Data Sheets submitted and approved prior to award. The supplier must also train personnel on SDS and labeling requirements and ensure all packaging and labeling meet the updated Federal Standard No. 313-E. Transportation of the shipment by sea must be conducted using U.S.-flag vessels unless a waiver is granted with prior documentation. The contract includes mandatory compliance with numerous DFARS clauses, including those addressing disclosure of information, whistleblower rights, restrictions on former DoD officials’ compensation, control of government work product, and NIST SP 800-171 cybersecurity requirements. The contractor must provide a Unique Entity Identifier and CAGE code, represent its small business status if applicable, and certify compliance with socioeconomic program requirements. Inspection and acceptance occur at destination, with full responsibility for quality, packaging, and regulatory compliance resting with the supplier. All proposals must be submitted electronically via the DLA Internet Bid Board System by the August 3, 2026 deadline, following DLA’s Master Solicitation for Automated Simplified Acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE TOPICAPOVIDONE-IODINE TOPICAL SOLUTION, USP, is a regulated pharmaceutical product procured under contract SPE2DP-26-T-4280 for U.S. military use, with each unit being a 4 fluid ounce (118 mL) bottle identified by the unit of issue BT and NSN 6505010672812. The product must comply with stringent technical and quality requirements from the DLA Master List, including a mandatory 36-month shelf life, of which at least 31 months must remain at time of delivery to the first government activity. Labeling must conform to MED.MARKING STD 1A, specifying key elements such as manufacturer and CAGE code, manufacturing and expiration dates, contract and lot numbers, and the unit designation 1 BT = 4 OZ. The product is subject to FDA regulation and requires pre-award referral through EBS for validation. Packaging must be commercial-grade, sealed to prevent damage, and shipped in exterior containers ensuring safe transit at minimal cost, adhering to DLA’s packaging directives over ASTM D3951 when applicable, with all marking strictly following MIL-STD-129 despite references to MMS No. 1. The material is classified as non-hazardous per FED-STD-313 and must be shipped by traceable means only, prohibiting parcel post. Two delivery points are specified: Fort Bragg, NC and Fort Bliss, TX, each requiring shipment within 20 days of contract award with no tolerance for quantity variance. Delivery is FOB destination, with inspection and acceptance occurring at the final location. The solicitation lists Cardinal Health 200, LLC and Purdue Pharma LP as potential manufacturers under NDC 67618-0150-04, and procurement is coordinated through DLA Troop Support, with point of contact Shairy M. Cartagena.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ZINC OXIDE OINTMENTZinc Oxide Ointment USP, containing 20% zinc oxide in a 28.35 gram collapsible tube, is a topical skin protectant procured under solicitation SPE2DP-26-T-4279 with a requirement for five units of issue. The product must comply with the latest Medical Marking Standard No. 1, be labeled with NDC 67777-0223-11, and be manufactured by Dynarex Corp under part number 1TVZ3. It is subject to a non-extendable shelf life of 36 months as a TYPE I Q-coded item and must be stored at controlled room temperature not exceeding 30°C. Packaging must adhere to DLA Packaging Requirements for Procurement, MIL-STD-129, and ASTM D3951 if non-hazardous, with all markings and labeling controlled by the DLA Master List of Technical and Quality Requirements. The item is regulated by the FDA, requiring referral through EBS for confirmation, and is subject to Covered Defense Information protocols. Delivery is FOB destination within 20 days of contract award, with no variance allowed in quantity, inspection and acceptance occurring at the destination point. The sole delivery address is W51JYU, 0165 CS HHC HHC Combat Sustainment, Bossier City, LA 71111-5397, and shipment must be sent via traceable means, excluding parcel post. The contract specifies a unit price of $5.00 per tube, totaling $25.00, with the original required delivery date set for July 28, 2026. All technical and quality obligations referenced by R-numbers are governed by the DLA Master List in effect on the solicitation issue date, and the product must be palletized in accordance with RP001. Government use only identifiers and tracking codes, including the TCN and SUPP ADD, are included for logistics and accountability purposes, with the contracting office listed as the Department of Defense, Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VECURONIUM BROMIDE FORVecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials per unit, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life, and storage must be maintained at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and retained in its original carton until use. The item is classified as a Type I (Code M) medical supply with a non-extendable shelf life, and all packaging and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers ensuring safe delivery at the lowest cost to the specified destination, with strict adherence to hazardous materials shipping protocols. The product, manufactured by Hikma Pharmaceuticals USA Inc., is identified by NDC 00143-9234-10 and NSN 6505-01-258-0983, and is required for delivery to JBER, Alaska, under contract SPE2DP-26-T-4283 with a firm delivery date of July 28, 2026. The procurement specifies a fixed quantity of three units totaling two packages, with no variance permitted, and all shipments must be routed through designated government freight and parcel post addresses. Compliance with DLA packaging, technical, and quality requirements, as outlined in the DLA Master List and supporting directives, is mandatory.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TOLNAFTATE POWDER, UThe contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of two BT units, each equivalent to 45 grams, under solicitation SPE2DP-26-T-4282. The item is designated as a Type I (Code Q) medical product with a strict non-extendable shelf life of 36 months, and packaging must comply with commercial standards as outlined in the procurement document, ensuring protection against damage and secure transit via common carrier at the lowest cost to the delivery point. All packaging and labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and includes proper identification and marking requirements for defense-related materials. Delivery is required FOB destination within five days, with no variance permitted in quantity, and inspection and acceptance occur at the destination. The item is sourced from Geri-Care Pharmaceuticals Corp. under NDC57896-0199-45, and the contract mandates compliance with DLA’s Technical and Quality Requirements as defined in the DLA Master List, with applicable provisions for Covered Defense Information. The place of performance is Mountain Home AFB, ID, and the contracting office is the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is subject to strict packaging and marking requirements mandated by the Department of Defense. Each unit must be sealed in a protective container to prevent damage or breakage, and all shipments must be packed in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all markings must adhere to the latest edition of this standard as published by DLA Troop Support. The product is regulated by the FDA and requires confirmation by a product specialist prior to award, with bidder and manufacturer details submitted through EBS. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure to up to 40°C permitted without adverse effects. It is prohibited from freezing and must be protected from excessive heat. The contract specifies a quantity of 2 packaging groups, each containing 12 units, for delivery to Dyess AFB within 20 days under FOB destination terms with zero variance allowed. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-330-6267 and manufacturer part number NDC00264-7750-00 under B. BRAUN MEDICAL INC. The solicitation, issued under contract SPE2DP-26-T-4292, has an August 3, 2026 response deadline and falls under NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLORThe contract specifies the procurement of test strips and color charts for urine analysis, detecting bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. Each unit of issue is a bottle containing 100 strips, and the item is identified by NSN 6550-01-221-5400 with a purchase quantity of four bottles. The product must comply with stringent technical and quality requirements referenced in the DLA Master List, and packaging must adhere to commercial standards as well as the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container, and shipping containers must ensure safe, cost-effective delivery to the specified FPO address. The item is classified as a Type I (Code K) with a non-extendable shelf life of 18 months, and no more than two months may have elapsed between the date of manufacture and the delivery date to the government. All labels must clearly indicate the date of manufacture, expiration or retest date, and the contract or lot number, in accordance with the latest MMS1C guidelines. The solicitation was issued under SPE2DS-26-T-269W with a response deadline of August 3, 2026, and delivery is required within 20 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

DEXTROSE, POTASSIUM CHLThe contract specifies the procurement of 1000 mL sterile injection solution containing 5 percent dextrose, 0.15 percent potassium chloride, and 0.45 percent sodium chloride, manufactured by Baxter Healthcare Corporation under NDC 00338-0671-04 and part number 2B1654X, packaged in units of 14 per pack (PG), with a total quantity of one unit. The item is regulated by the FDA and subject to strict packaging, marking, and shelf-life requirements; it must have a non-extendable 24-month shelf life and be commercially packaged to protect against damage during transit. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over other standards such as ASTM D3951. Hazardous material handling protocols under FED-STD-313 and TQ requirement IP025 apply if applicable. The item must be palletized in accordance with DLA packaging requirements, shipped via the fastest traceable means excluding parcel post, and delivered FOB destination to Fort Stewart, Georgia within 20 days of contract award. The required delivery date is July 24, 2026, with zero variance allowed in quantity. The solicitation number is SPE2DP-26-T-4278, with a response deadline of August 3, 2026, and the North American Industry Classification System code is 325412. Government use designation and shipping instructions include specific codes and identifiers for logistics and tracking purposes.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGEThe contract specifies the procurement of Chlorine Test Reagent, a DPD total chlorine reagent supplied in 100 powder pillows, each designed for a 10 mL sample size, with the unit of issue being one package containing 100 pillows. The item is identified by NSN 6550-01-460-7597 and must meet stringent technical and quality requirements referenced from the DLA Master List of Technical and Quality Requirements. It is subject to DLA packaging standards, including commercial packaging for all medical acquisitions, requiring each unit to be sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery at the lowest carrier rate. All markings must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the date of manufacture, expiration or retest date, and the contract or lot number in accordance with the latest revision of MMS1C. The item is classified as a TYPE I (CODE S) with a mandatory 60-month shelf life that is non-extendable, and no more than eight months may have passed between the date of manufacture and the date of delivery to the government. The solicitation, issued under SPE2DS-26-T-269Y on July 26, 2026, requires delivery within 20 days after order and is managed by the Department of Defense’s Medical Supply Chain, with Seth Tootell as the primary point of contact.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP in 500 mL units, packaged 24 per case, is procured under contract SPE2DP-26-T-4281 with a total quantity of two cases, delivered FOB destination within 20 days. Each case must contain intact, sealed unit containers protecting the product from damage, with exterior shipping containers compliant with commercial standards and marked according to Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The item has a non-extendable shelf life of 18 months, requiring at least 15 months of remaining shelf life upon delivery to the first government activity, and must be stored at controlled room temperature not exceeding 25°C. The product is regulated by the FDA, with supplier and manufacturer details including B. B Braun Medical Inc. and Baxter Healthcare Corp, identified by NDC 00264-7750-10 and part numbers L7501 and 2B2323Q. Packaging and quality requirements adhere to the DLA Master List of Technical and Quality Requirements, with all procurement governed by DLA packaging and medical acquisition standards. The National Stock Number is 6505014623022, and the unit of issue is PG, where one PG equals 24 units. Inspection and acceptance occur at the destination, with no variance allowed in quantity. Delivery is to Fort Bliss, Texas, with primary point of contact Daniel Porter at DLA Troop Support.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Same awarding agency

Medical Product Labeling and Bar-CodingThe contract requires the application of MMS No. 1-compliant labels and barcodes to medical products and their packaging for delivery to the Department of Defense, ensuring full adherence to federal hazard communication standards. This includes accurate labeling for safety, identification, and tracking, with all markings meeting strict military specifications for legibility, durability, and regulatory compliance. The work must be performed in alignment with the MMS No. 1 standard, which governs the formatting, content, and placement of labels on medical items intended for DoD use. The solicitation is classified as a subcontract under NAICS code 323121, reflecting its focus on printing and related support activities. It is open for responses until August 3, 2026, with performance destined for APO 09227-0000. The activity is managed by the Medical Supply Chain MD Surg FSF within the Department of Defense, and bidders must ensure their processes support end-to-end traceability and compliance with military supply chain requirements for medical logistics.

Tradebinding and Related Work

POSTED

DEADLINE

Hazardous Materials Packaging and PreservationThe contract requires the design and supply of specialized packaging systems compliant with MIL-STD-2073-1E and DLA RP001 standards to preserve frozen human serum controls during international transport, ensuring a guaranteed 24-month shelf life under controlled conditions. The packaging must be engineered to maintain cryogenic integrity throughout shipment, withstand extreme environmental stresses, and meet strict hazardous materials handling protocols for global logistics. The solution must integrate robust thermal insulation, impact-resistant materials, and validated cold chain technologies to prevent degradation of the serum controls from production to final use. Performance is centered on the APO 09227-0000 location with delivery expected to support Department of Defense medical supply chains, specifically under the MEDICAL SUPPLY CHAIN MD SURG FSF. The effort falls under NAICS code 322291, indicating classification as other paper product manufacturing, and is structured as a subcontract opportunity with a narrow response window closing on August 3, 2026. All packaging systems must undergo rigorous validation to prove consistent performance across diverse climate zones and extended transit times, with compliance documentation and testing reports required to demonstrate adherence to military and logistics preservation standards without exception.

Sanitary Paper Product Manufacturing

POSTED

DEADLINE

Cold Chain Logistics and Specialized TransportationThe contract encompasses the specialized transportation of frozen biological materials requiring strict temperature control between -20°C and -70°C, moving these sensitive payloads from the manufacturer to APO and various locations in Germany. This subcontract mandates the use of certified, temperature-monitored freight services to ensure the integrity and safety of the biological materials throughout transit, with compliance to stringent cold chain protocols being non-negotiable. The logistics operation must guarantee uninterrupted thermal stability, real-time monitoring, and documented evidence of temperature adherence at every stage of the journey. Issued under the NAICS code 484220 for specialized freight transportation, this solicitation is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office. The response deadline is August 3, 2026, with performance centered on the APO ZIP code 09227-0000 as the primary point of delivery, alongside multiple endpoints in Germany. The nature of the cargo demands end-to-end traceability, secure handling procedures, and adherence to federal regulations governing the transport of biohazardous and thermally sensitive medical materials, making this a high-stakes logistics engagement requiring certified expertise in pharmaceutical and biological cold chain distribution.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Manufacturer of Assayed Human Serum ControlsThe contract requires the manufacture of liquid human serum-based, level 3 assayed controls containing over 50 analytes for use in clinical chemistry testing, with strict adherence to FDA compliance standards and certified assay accuracy to ensure reliable diagnostic performance. The controls must meet rigorous quality benchmarks to support clinical laboratories in maintaining precision and traceability across a broad spectrum of biochemical parameters. The solicitation is issued under the Department of Defense’s Medical Supply Chain MD Surg FSF as a subcontract, with a response deadline of August 3, 2026, and a place of performance designated as APO 09227-0000. The North American Industry Classification System code 325414 identifies the work as falling under pharmaceutical and medicinal chemical manufacturing, emphasizing the need for specialized expertise in biological product formulation. All deliverables must be fully compliant with regulatory requirements, and the manufacturer is expected to demonstrate proven capability in producing high-integrity analytical controls under controlled conditions.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Unable to identify sub-opportunities due to insufficient dataThe contract is a subcontract opportunity issued by the Department of Defense under the Medical Supply Chain MD Surg FSF, with a posted date of July 26, 2026, and a response deadline of August 3, 2026. The place of performance is located in Annville, Pennsylvania, with a zip code of 17003-0000, though no additional details are provided regarding the office address or point of contact. The solicitation number is not available, and the NAICS code is listed as NA, indicating incomplete or missing classification data. The type of set aside and its description are also undefined, making it unclear if any small business or other socioeconomic preferences apply. Critical elements necessary for evaluating the opportunity—including the Statement of Work, Contract Line Item Numbers, and pricing structure—are insufficiently documented, severely limiting the ability to identify potential subcontract or supplier engagements. Without these core components, bidders cannot assess the scope, deliverables, or financial terms. The only available reference is a DIBBS link for the solicitation, but the lack of essential information renders the opportunity unactionable for most interested parties until further details are released.

POSTED

DEADLINE

Hazardous Materials Logistics & DeliveryThe contract pertains to the transportation of medical supplies classified as hazardous materials, requiring full compliance with all applicable federal regulations governing the safe handling, labeling, and movement of such substances. Delivery must be executed under FOB Destination terms, meaning ownership and risk transfer to the recipient only upon arrival at the specified destination, Fort Stewart, GA, with the contractor responsible for all logistics, documentation, and safety protocols until the cargo is received. The work falls under NAICS code 484220, indicating it involves specialized freight transportation services, and is structured as a subcontract within the Department of Defense’s Medical Supply Chain framework. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026, and performance must align with federal standards and the specific needs of the Fort Stewart installation, identified by the zip code 31314-5185.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Medical Device Packaging & Labeling ServicesThe contract requires the packaging and labeling of oxygen masks in full compliance with DLA standards, specifically under MMS No. 1, ensuring all items are properly barcoded and equipped with lot traceability for end-to-end supply chain visibility. Rejected items must have all government markings removed prior to disposal or return, maintaining strict adherence to security and compliance protocols. The work is classified as a subcontract under the NAICS code 325991 and is tied to the Department of Defense’s Medical Supply Chain division, with performance designated to occur at Fort Stewart, Georgia, 31314-5185. All proposals must be submitted by August 3, 2026, following the solicitation posted on July 26, 2026. The contract is part of a broader medical logistics initiative managed by the Defense Logistics Agency, emphasizing precision in packaging, labeling, and traceability for critical medical devices used in military healthcare operations. Compliance with regulatory and procedural requirements is essential, and failure to meet packaging, marking, or traceability standards may result in rejection of delivery. The effort supports assured readiness of life-sustaining equipment for deployed personnel.

Custom Compounding of Purchased Resins

POSTED

DEADLINE

Regulatory Compliance & Safety Data DocumentationThe contract requires the preparation and submission of Material Safety Data Sheets MSDS hazard labels and related compliance documentation to meet the stringent requirements of DFARS 252.223-7001 and OSHA standards ensuring all chemical and material safety information is accurately documented and properly labeled for DoD supply chain use. This work is critical for ensuring regulatory adherence across the medical supply chain and includes generating hazard communication materials that align with federal mandates for workplace safety and defense logistics. The solicitation is categorized as a subcontract under NAICS code 541690 and is issued by the Department of Defense through the Medical Supply Chain MD Surg FSF with performance required at Fort Stewart Georgia 31314-5185. The response deadline is August 3 2026 and the solicitation was posted on July 26 2026. All submissions must demonstrate full compliance with federal regulations regarding chemical safety disclosures and labeling protocols with an emphasis on precision and timeliness to support DoD operational readiness and safety obligations.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Disposable Rebreathing Oxygen Mask ManufacturingThe contract seeks the manufacture and supply of disposable adult rebreathing oxygen masks that meet strict technical specifications outlined by the Defense Logistics Agency, identified by NSN 6515-01-519-6766. These masks must comply with rigorous standards for material safety, biocompatibility, and packaging to ensure clinical effectiveness and patient protection. All products are intended for use in military medical environments and must adhere to performance and quality benchmarks established by the Department of Defense. The place of performance is designated as Fort Stewart, Georgia, with deliveries expected to support ongoing medical supply operations at this location. This is a subcontract opportunity under the NAICS code 339112, which pertains to medical equipment and supplies manufacturing. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026, allowing qualified manufacturers a limited window to submit proposals. While the solicitation number is not provided, interested parties can access further details through the official DIBBS portal using the provided link. This procurement is part of the Medical Supply Chain under the Department of Defense, ensuring that frontline medical personnel have reliable, single-use oxygen delivery systems consistent with military health and safety mandates.

Surgical and Medical Instrument Manufacturing

POSTED

DEADLINE

Packaging and Labeling Compliance for Medical SuppliesThe contract requires strict adherence to MIL-STD-2073-1E preservation standards for packaging medical supplies, ensuring that all items are protected against environmental damage during storage and transit. Labeling must fully comply with Medical Marking Standard No. 1, incorporating mandatory data elements such as the National Stock Number, CAGE code, lot number, and expiration date to support traceability and inventory management across the defense supply chain. All packaging and labeling processes must be executed with precision to meet military specifications and avoid non-compliance penalties. This is a subcontract opportunity issued by the Department of Defense under the Medical Supply Chain MD SURG FSF, with performance expected at Scott Air Force Base, Illinois, ZIP 62225-5252. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026. The NAICS code 561910 categorizes this under Other Support Activities for Transportation, indicating the focus on logistics and support services tied to medical supply handling. The contract is not set aside for any specific small business category, and vendors must ensure their processes align fully with federal military standards to qualify for award.

Packaging and Labeling Services

POSTED

DEADLINE

Cybersecurity Compliance for Covered Defense Information (CDI)The contract requires the implementation and maintenance of cybersecurity controls aligned with NIST SP 800-171 to safeguard covered defense information handled by the subcontractor. This includes ensuring all systems and processes meet the specified technical and operational requirements to protect sensitive data originating from Department of Defense sources. Continuous compliance is mandatory, with strict adherence to incident reporting protocols requiring notification within 72 hours of any cybersecurity breach or compromise, alongside the preservation of all relevant forensic data for potential investigation and audit purposes. Performance is tied to the Scott Air Force Base location, and the work falls under NAICS code 541512, indicating it involves computer systems design services. The contract is structured as a subcontract under the Medical Supply Chain MD Surg FSF division of the Department of Defense, with a response deadline of August 3, 2026. There is no set-aside designation specified, and the subcontractor must be prepared to meet all federal cybersecurity obligations without exception, as any failure in compliance could result in contract termination or penalties.

Computer Systems Design Services

POSTED

DEADLINE

Hazardous Materials Compliance and Safety Data Sheet (SDS) ManagementThe contract requires the preparation and ongoing maintenance of Safety Data Sheets (SDS) in strict compliance with OSHA 29 CFR 1910.1200 and Department of Defense regulations, ensuring that all hazardous materials documentation meets federal safety and reporting standards. This includes submitting SDS documents prior to award as part of the pre-award process and promptly updating them whenever there are changes to product formulations, ensuring continuous regulatory adherence and accurate hazard communication. The work is scoped as a subcontract under the NAICS code 541690, with performance location set at Scott Air Force Base, Illinois, and the solicitation is managed by the Medical Supply Chain MD Surg FSF under the Department of Defense. Responses are due by August 3, 2026, and the contract is not designated with any specific set-aside status.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE